Graph Therapeutics raises $5M to build its own drugs

Graph Therapeutics, founded by Allcyte co-founder Gregory Vladimer, raised $5M from Daphni to develop its own medicines. The Vienna-based startup targets inflammation and immunology diseases by testing drugs on living patient cells and applying machine learning. Total funding now exceeds $10M.